Table 3.
UDT Results Among Chronic Opioid Therapy Patients in Each Study Year
| UDT result | Baseline year N = 460 UDTs n (%) |
Planning year N = 895 UDTs n (%) |
Implementation year N = 3,445 UDTs n (%) |
|---|---|---|---|
| Positive for 6-AM, amphetamine, cocaine, MDMA, methamphetamine, PCP, or THC | 56 (12.2) | 128 (14.3) | 434 (12.6) |
| Positive for THC | 43 (9.4) | 106 (11.8) | 381 (11.1) |
| Positive for cocaine | 8 (1.7) | 6 (0.7) | 13 (0.4) |
| Positive for amphetamine | 9 (2.0) | 17 (1.9) | 55 (1.6) |
| Positive for methamphetamine | 1 (0.2) | 6 (0.7) | 7 (0.2) |
| Specimen too dilute to analyze* | 34 (7.4) | 53 (5.9) | 151 (4.4) |
6-AM 6-acetylmorphine (heroin); MDMA 3,4-methylenedioxymethamphetamine (ecstasy); PCP phencyclidine; THC tetrahydrocannabinol (marijuana); UDT urine drug test
*Dilute urines can result from a variety of causes, including a purposeful attempt to make the results not analyzable